![Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens | npj Vaccines Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-020-0204-7/MediaObjects/41541_2020_204_Fig1_HTML.png)
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens | npj Vaccines
![Ebola ring vaccination participants' sample size calculation (Central... | Download Scientific Diagram Ebola ring vaccination participants' sample size calculation (Central... | Download Scientific Diagram](https://www.researchgate.net/profile/Tamuzi-Lukenze-Jacques/publication/330479242/figure/fig1/AS:716402067509252@1547814971861/Ebola-ring-vaccination-participants-sample-size-calculation-Central-and-non-central_Q640.jpg)
Ebola ring vaccination participants' sample size calculation (Central... | Download Scientific Diagram
![Press Release: First Ebola Vaccine to Be Tested in Affected Communities One Year into Outbreak Ring Vaccination Starts in Coyah, Guinea (25.03.2015) – MinBane Press Release: First Ebola Vaccine to Be Tested in Affected Communities One Year into Outbreak Ring Vaccination Starts in Coyah, Guinea (25.03.2015) – MinBane](https://minbane.files.wordpress.com/2015/03/ebola-vaccine-market-analysis-5-638.jpg)
Press Release: First Ebola Vaccine to Be Tested in Affected Communities One Year into Outbreak Ring Vaccination Starts in Coyah, Guinea (25.03.2015) – MinBane
![Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2e56607a-ace7-42b4-a6a5-cab5547613e8/gr3_lrg.jpg)
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases
![John Libbey Eurotext - Virologie - Anti-Ebola vaccination of humans using a chimeric virus: rational of a hope John Libbey Eurotext - Virologie - Anti-Ebola vaccination of humans using a chimeric virus: rational of a hope](https://www.jle.com/e-docs/00/04/AA/8F/jlevir0621gr1.jpg)
John Libbey Eurotext - Virologie - Anti-Ebola vaccination of humans using a chimeric virus: rational of a hope
![Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) — Center for Inference and Dynamics of Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) — Center for Inference and Dynamics of](https://images.squarespace-cdn.com/content/v1/53d8f599e4b0ba978ec978d1/1482951467078-DD5Z0RL1T83TYBHB67N2/Ebola+fig.jpg?format=2500w)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) — Center for Inference and Dynamics of
![The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ](https://www.bmj.com/content/bmj/351/bmj.h3740/F2.large.jpg)
The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ
![Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2116683534/2085057685/gr1.jpg)
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report - The Lancet Infectious Diseases
![The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ](https://www.bmj.com/content/bmj/351/bmj.h3740/F1.large.jpg)
The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola | The BMJ
![Ring vaccination of COVID‐19 vaccines in medium‐ and high‐risk areas of countries with low incidence of SARS‐CoV‐2 infection - Xu - 2021 - Clinical and Translational Medicine - Wiley Online Library Ring vaccination of COVID‐19 vaccines in medium‐ and high‐risk areas of countries with low incidence of SARS‐CoV‐2 infection - Xu - 2021 - Clinical and Translational Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/63c21e36-c776-43e1-a926-74bf00d9b1cf/ctm2331-fig-0001-m.jpg)
Ring vaccination of COVID‐19 vaccines in medium‐ and high‐risk areas of countries with low incidence of SARS‐CoV‐2 infection - Xu - 2021 - Clinical and Translational Medicine - Wiley Online Library
![Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC - Health Policy Watch Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC - Health Policy Watch](https://www.healthpolicy-watch.org/wp-content/uploads/2019/04/WHO-ring-vacc-chart.jpg)